ENT Devices Market - By Product Type, By End Use, Global Forecast, 2024 - 2032

ENT Devices Market Size

The global ENT devices market size was valued at USD 20.8 billion in 2023 and is anticipated to witness growth at a CAGR of 6.3% from 2024 to 2032. There is an increase in the market for ENT devices due to factors such as increasing population suffering from ENT disorders, increased surgical and diagnostic procedures for ENT. Also, few of the factors such as the types of surgeries being performed, and technological advancements in devices such as microscopes, endoscopes, and robotic surgeries, are further augmenting the market.
 

In addition, it has been observed an increasing market for cochlear implants and hearing aids which is boosting the ENT market. The global elderly population is increasing the prevalence of hearing impairment, driving the demand for hearing aids and cochlear implants. Modern features of smart hearing aids that use Bluetooth technology and contain noise cancelling features are further enhancing the user experience and therefore increasing the market.
 

Furthermore, an increase in the anticipated surgeries and diagnostic examinations has a favorable relation to the improvement in ENT apparatus utilized within the health institutions. Increased sophistication of procedures results in the increased sophistication of devices employed to regulate the environment for better sterility, cross contamination, and HCW and patient protection. For instance, a greater population with sleep apnea and chronic sinusitis means more sophisticated ENT devices are needed for diagnosis and treatment. Also, the shift toward treatment being provided on an outpatient basis only and in-day care is also changing the market for ENT devices. These kinds of ENT appliances are in much demand because they are simple to use, and patients want value oriented and easily accessible healthcare.
 

ENT Devices Market Trends

• Sophisticated technology such as lasers, robots, guided surgeries and HD imaging greatly improved the market dynamics, as it made the whole surgery intricate and extremely great as well.
   
• With the new advances, doctors are now able to perform complex operations through tiny cuts, which reduces blood loss and increases precision and overall better results for the patients.
   
• There are advantages with novel techniques that patients prefer today, leaving open surgery as a last option because it leads to less pain, has a shorter recovery time, reduces the length of hospitalization, and produces small scars.
   
• Additionally, routine activities pertaining to R&D are also expected to positively impact the growth of the market. For instance, in July 2023, Atrium Health investigators received a USD 3.2 million grant for research on computer-assisted diagnosis of ear disorders.
   
• Moreover, there are already existing policies and regulations that these devices have to meet that promote the safety and effectiveness of ENT devices such as the U.S. FDA and the European Medicines Agency. These policies have to be met by the device manufacturers who wish to be competitive within the industry and ensure the safety of the devices, thus increasing the use of good, certified ENT devices, thereby augmenting the market growth.
   

ENT Devices Market Analysis

Based on product type, the market is segmented into diagnostic ear, nose, and throat (ENT) devices, surgical ear, nose, and throat (ENT) devices, hearing aids, hearing implants, voice prosthesis devices, and nasal splints. The hearing aids segment held a dominant market share of 37.2% in 2023.
 

• Factors such as the application of hearing amplification gadgets particularly by the elderly, rivalry among technology firms in the development of hearing aids & hearing amplifiers, as well as improved ease of use are some of the reasons behind the progress in the hearing aids segment. For instance, Starkey indicated that in February 2023, it will launch its latest hearing device Genesis AI. The device comprises better processors and new features aimed at enhancing patient experience.
   
• Further, an increasing number of people understand the issue of hearing loss and the impact on their life and are thus more prepared to be treated. Also, government programs and health policies concerning hearing aids in emerging markets make it easier for people to access them, thereby fostering the market size.
   

Based on end use, the ENT devices market is segmented into hospitals, ambulatory surgical centres, ENT clinics, and homecare. The hospitals segment held a dominant market share of 36% in 2023.
 

• The employed diagnostic endoscopes and surgical equipment is gradually augmenting in hospitals. Increased productivity of surgical technology has led to the development of more sophisticated and accurate diagnostic tools. For instance, along with standard endoscopes, there are now HD endoscopes and other advanced imaging techniques used to enhance the precision of diagnosis and treatment planning.
   
• Moreover, the increasing number of ENT problems such as chronic sinusitis, sleep apnea and hearing problems among others, are likely to escalate the demand for these new and advanced diagnostic and surgical tools. Therefore, the hospitals are investing great amounts in purchasing quality ENT tools to meet the demand.
   

North America ENT devices market size in 2023 was valued at USD 8.1 billion and is predicted to grow at a CAGR of 5.2% over the analysis timeframe.
 

• The U.S. has a high prevalence of ENT diseases which, combined with high spending in the sector, robust R&D investments, and advanced ENT device healthcare facilities and favorable reimbursement processes, encourages adoption of ENT devices.
   
• Moreover, measurable indicators are also expected to increase because of these campaigns. For instance, GN Hearing, in March 2024, launched a campaign aimed at decreasing the skepticism surrounding hearing aids.
   
• Thus, the aforementioned factors along with increase in elderly population and education on ENT are also responsible for the growth in the market.
   

UK ENT devices market is projected to grow remarkably in the coming years.
 

• The demand in the UK is driven by a developed healthcare system (NHS), rise in prevalence of ENT disorders, and government schemes for early diagnosis and treatment. Also, technological development and awareness among patients are driving the country level market.
   

China is experiencing high market growth in the ENT devices market.
 

• In China, urbanization, healthcare spending, and a rising number of ENT diseases are contributing to increased demand.
   
• Moreover, the rise in income levels as well as enhancement of ENT awareness is expected to drive the market for ENT devices due to the growth of healthcare infrastructure.
   

ENT Devices Market Share

There are many established companies within the market. Moreover, there are also new companies providing treatment in different parts of the world. Because of this, the players compete in areas such as servicing, innovation, treatment quality, regulation, and even price.
 

ENT Devices Market Companies

Prominent players operating in the ENT devices industry include:

• Atos Medical
• Boston Scientific Corporation
• Cochlear
• DeSoutter Medical
• Johnson & Johnson
• Lumenis
• Medtronic
• Meril Life Sciences
• Narang Medical
• Nouvag
• Olympus Corporation
• Smith & Nephew
• Sonova Group
• Stryker Corporation
• Vega Medical
• Welch Allyn
• WestCMR
• Zimmer Biomet
   
• Medtronic offers cutting-edge ENT operational tools and navigation systems, which are crafted to improve target accuracy and maximize patient results.
   
• Stryker specializes in advanced imaging and devices for the surgeons practicing in the ENT field.
   
• Smith & Nephew focuses on new ideas for the design of ENT products, such as pain-free devices which improve the speed of surgery and recovery.
   

ENT Devices Industry News: 

• In April 2022, NYU Langone Health launched a new hearing loss screening program for low-income individuals.
   
• In May 2023, Olympus received FDA approval for its new EVIS X1 endoscopy system. The endoscopes are compatible with upper gastrointestinal examinations.
   

The ENT devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Market, By Product Type

• Diagnostic ear, nose, and throat (ENT) devices
  • Rigid endoscopes
    • Rhinoscopes
    • Laryngoscopes
    • Otological endoscopes
  • Flexible endoscopes
  • Robot assisted endoscopes
  • Hearing screening devices
• Surgical ear, nose, and throat (ENT) devices
  • Radiofrequency handpieces
  • Powered surgical instruments
  • Otological drill burrs
  • ENT hand instruments
  • Tympanostomy tubes
  • Sinus dilation devices
  • Nasal packing devices
• Hearing aids
  • Behind-the-ear (BTE)
  • Completely-in-the-canal/Invisible-in-canal (CIC/IIC)
  • In-the-canal [In-the-canal (ITC)]
  • In-the-ear (ITE)
  • Receiver in the ear/Receiver in canal (RITE/RIC)
• Hearing implants
  • Auditory brainstem implants
  • Cochlear implants
  • Middle ear implants
  • Bone anchored hearing systems
• Voice prosthesis devices
• Nasal splints
  • Internal nasal splints
  • External nasal splints

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• ENT clinics
• Homecare

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey